The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Performance of a blood-based test for the detection of multiple cancer types.
 
Brian M. Wolpin
Honoraria - Celgene; Celgene; Celgene; Celgene; G1 Therapeutics; G1 Therapeutics; G1 Therapeutics; G1 Therapeutics
Consulting or Advisory Role - BioLineRx; BioLineRx; BioLineRx; BioLineRx; Celgene; Celgene; Celgene; Celgene; G1 Therapeutics; G1 Therapeutics; G1 Therapeutics; G1 Therapeutics; Genentech; Genentech; Genentech; Genentech; GRAIL; GRAIL; GRAIL; GRAIL; GRAIL; GRAIL; GRAIL; GRAIL
Research Funding - Celgene; Celgene; Celgene; Celgene; Lilly; Lilly; Lilly; Lilly
 
Donald A. Richards
Consulting or Advisory Role - Ipsen; Ipsen; Ipsen; Ipsen; Seattle Genetics/Astellas; Seattle Genetics/Astellas; Seattle Genetics/Astellas; Seattle Genetics/Astellas; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
 
Allen Lee Cohn
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Ipsen; Ipsen; Ipsen
Speakers' Bureau - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Ipsen; Ipsen; Ipsen
 
Xiaoji Chen
Employment - GRAIL; GRAIL; GRAIL; GRAIL
Stock and Other Ownership Interests - GRAIL; GRAIL; GRAIL; GRAIL; Illumina (I); Illumina (I); Illumina (I); Illumina (I)
Research Funding - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst)
Travel, Accommodations, Expenses - GRAIL; GRAIL; GRAIL; GRAIL
 
Joerg Bredno
Employment - GRAIL; GRAIL; GRAIL; GRAIL
Stock and Other Ownership Interests - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst)
Research Funding - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst)
Patents, Royalties, Other Intellectual Property - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst)
 
Kathryn N. Kurtzman
Employment - GRAIL; GRAIL; GRAIL; GRAIL
Stock and Other Ownership Interests - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); Illumina; Illumina; Illumina; Illumina
Research Funding - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst)
 
Jessica Yecies
Employment - GRAIL; GRAIL; GRAIL; GRAIL
Stock and Other Ownership Interests - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst)
Research Funding - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst)
 
Rita Shaknovich
Employment - GRAIL; GRAIL; GRAIL; GRAIL
Stock and Other Ownership Interests - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst)
Research Funding - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst)
 
Nan Zhang
Employment - GRAIL; GRAIL; GRAIL; GRAIL
Stock and Other Ownership Interests - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst)
Research Funding - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst)
 
Mohan K. Tummala
No Relationships to Disclose
 
David R. Spigel
Leadership - TriStar Centennial Medical Center; TriStar Centennial Medical Center; TriStar Centennial Medical Center; TriStar Centennial Medical Center
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Evelo Therapeutics (Inst); Evelo Therapeutics (Inst); Evelo Therapeutics (Inst); Evelo Therapeutics (Inst); Foundation Medicine (Inst); Foundation Medicine (Inst); Foundation Medicine (Inst); Foundation Medicine (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Illumina (Inst); Illumina (Inst); Illumina (Inst); Illumina (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Moderna Therapeutics (Inst); Moderna Therapeutics (Inst); Moderna Therapeutics (Inst); Moderna Therapeutics (Inst); Nektar (Inst); Nektar (Inst); Nektar (Inst); Nektar (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); PharmaMar (Inst); PharmaMar (Inst); PharmaMar (Inst); PharmaMar (Inst); Precision Oncology (Inst); Precision Oncology (Inst); Precision Oncology (Inst); Precision Oncology (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); TRM Oncology (Inst); TRM Oncology (Inst); TRM Oncology (Inst); TRM Oncology (Inst)
Research Funding - Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Acerta Pharma (Inst); Acerta Pharma (Inst); Acerta Pharma (Inst); Acerta Pharma (Inst); Aeglea Biotherapeutics (Inst); Aeglea Biotherapeutics (Inst); Aeglea Biotherapeutics (Inst); Aeglea Biotherapeutics (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); ARMO BioSciences (Inst); ARMO BioSciences (Inst); ARMO BioSciences (Inst); ARMO BioSciences (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celldex (Inst); Celldex (Inst); Celldex (Inst); Celldex (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); EMD Serono (Inst); EMD Serono (Inst); EMD Serono (Inst); Foundation Medicine (Inst); Foundation Medicine (Inst); Foundation Medicine (Inst); Foundation Medicine (Inst); G1 Therapeutics (Inst); G1 Therapeutics (Inst); G1 Therapeutics (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Millennium (Inst); Millennium (Inst); Millennium (Inst); Millennium (Inst); Nektar (Inst); Nektar (Inst); Nektar (Inst); Nektar (Inst); Neon Therapeutics (Inst); Neon Therapeutics (Inst); Neon Therapeutics (Inst); Neon Therapeutics (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Oncogenex (Inst); Oncogenex (Inst); Oncogenex (Inst); Oncogenex (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); Tesaro (Inst); Tesaro (Inst); Tesaro (Inst); Tesaro (Inst); Transgene (Inst); Transgene (Inst); Transgene (Inst); Transgene (Inst); University of Texas Southwestern Medical Center - Simmons Cancer Center (Inst); University of Texas Southwestern Medical Center - Simmons Cancer Center (Inst); University of Texas Southwestern Medical Center - Simmons Cancer Center (Inst); University of Texas Southwestern Medical Center - Simmons Cancer Center (Inst)
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; EMD Serono; EMD Serono; EMD Serono; EMD Serono; Genentech; Genentech; Genentech; Genentech; Genzyme; Genzyme; Genzyme; Genzyme; Intuitive Surgical; Intuitive Surgical; Intuitive Surgical; Intuitive Surgical; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; Pfizer; Pfizer; Pfizer; Pfizer; Purdue Pharma; Purdue Pharma; Purdue Pharma; Purdue Pharma; Spectrum Pharmaceuticals; Spectrum Pharmaceuticals; Spectrum Pharmaceuticals; Spectrum Pharmaceuticals; Sysmex; Sysmex; Sysmex; Sysmex
 
David Cosgrove
Employment - Biocompatibles; Biocompatibles; Biocompatibles; Biocompatibles; Compass Oncology; Compass Oncology; Compass Oncology; Compass Oncology
Leadership - US Oncology; US Oncology; US Oncology; US Oncology
Consulting or Advisory Role - Biocompatibles; Biocompatibles; Biocompatibles; Biocompatibles
Speakers' Bureau - Biocompatibles; Biocompatibles; Biocompatibles; Biocompatibles
Travel, Accommodations, Expenses - US Oncology; US Oncology; US Oncology; US Oncology
 
Sharon Wilks
Research Funding - Seagen (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst)
 
Robert D. Siegel
Research Funding - Altor BioScience (Inst); Altor BioScience (Inst); Altor BioScience (Inst); Altor BioScience (Inst); Apollomics (Inst); Apollomics (Inst); Apollomics (Inst); Apollomics (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Calithera Biosciences (Inst); Calithera Biosciences (Inst); Calithera Biosciences (Inst); Cancer Insight (Inst); Cancer Insight (Inst); Cancer Insight (Inst); Cancer Insight (Inst); CerRx (Inst); CerRx (Inst); CerRx (Inst); CerRx (Inst); Exact Sciences (Inst); Exact Sciences (Inst); Exact Sciences (Inst); Exact Sciences (Inst); Galera Therapeutics (Inst); Galera Therapeutics (Inst); Galera Therapeutics (Inst); Galera Therapeutics (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Mirati Therapeutics (Inst); Mirati Therapeutics (Inst); Mirati Therapeutics (Inst); Mirati Therapeutics (Inst); Strata Oncology (Inst); Strata Oncology (Inst); Strata Oncology (Inst); Strata Oncology (Inst)
Other Relationship - American Board of Internal Medicine (ABIM); American Board of Internal Medicine (ABIM); American Board of Internal Medicine (ABIM); American Board of Internal Medicine (ABIM)
 
Eric T. Fung
Employment - GRAIL; GRAIL; GRAIL; GRAIL
Stock and Other Ownership Interests - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst)
Research Funding - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst)
Patents, Royalties, Other Intellectual Property - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst)
Travel, Accommodations, Expenses - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst)
 
Arash Jamshidi
Employment - GRAIL; GRAIL; GRAIL; GRAIL
Stock and Other Ownership Interests - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); Illumina; Illumina; Illumina; Illumina
Research Funding - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst)
Patents, Royalties, Other Intellectual Property - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst)
 
Alex Aravanis
Employment - GRAIL; GRAIL; GRAIL; GRAIL
Leadership - GRAIL; GRAIL; GRAIL; GRAIL
Stock and Other Ownership Interests - GRAIL; GRAIL; GRAIL; GRAIL
Consulting or Advisory Role - Foresite Laboratories; Foresite Laboratories; Foresite Laboratories; Foresite Laboratories
 
Anne-Renee Hartman
Employment - GRAIL; GRAIL; GRAIL; GRAIL
Stock and Other Ownership Interests - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst)
Research Funding - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst)
Travel, Accommodations, Expenses - GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst)
 
Minetta C. Liu
Research Funding - Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); GRAIL (Inst); Janssen Diagnostics (Inst); Janssen Diagnostics (Inst); Janssen Diagnostics (Inst); Janssen Diagnostics (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Tesaro (Inst); Tesaro (Inst); Tesaro (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Agena Bioscience; Agena Bioscience; Agena Bioscience; Agena Bioscience; Celgene; Celgene; Celgene; Celgene; Cynvenio Biosystems; Cynvenio Biosystems; Cynvenio Biosystems; Cynvenio Biosystems; Genomic Health; Genomic Health; Genomic Health; Genomic Health; GRAIL; GRAIL; GRAIL; GRAIL; Menarini Silicon Biosystems; Menarini Silicon Biosystems; Menarini Silicon Biosystems; Menarini Silicon Biosystems; Merck; Merck; Merck; Merck; Pfizer; Pfizer; Pfizer; Pfizer
 
Eric A. Klein
Consulting or Advisory Role - Cellanyx Diagnostics; Cellanyx Diagnostics; Cellanyx Diagnostics; Cellanyx Diagnostics; GRAIL; GRAIL; GRAIL; GRAIL